3 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: Grant for Multiple Sclerosis Innovation
The deadline for grant applications is 28 February 2014.
The innovation grant will be awarded to support promising translational research projects by academic researchers to improve understanding of MS for the ultimate benefit of patients. Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programmes, mobile health devices, or patient-reported outcomes. To be eligible to apply, applicants must have preliminary data to support their proposal.
A total grant of up to €1,000,000 will be awarded to one or more selected projects. The grant will build on the success of the Grant for Fertility Innovation (GFI), which has awarded grants that total up to €6,000,000 to translational research projects since 2010.
Applications are invited from around the world and will be reviewed by the Scientific Committee against the following criteria:
Relevance to clinical practice
For further information on the GMSI and to register your interest in applying for the GMSI 2014, please contact: email@example.com
Progressive MS Alliance Challenge Awards and Infrastructure Awards
Deadline - January 31, 2014
The Progressive MS Alliance (previously known as the International Progressive MS Collaborative) is working together to find answers and develop solutions to end progressive MS. The Alliance aims to build upon current research efforts and connect resources and experts around the world. The Alliance is pleased to announce two new funding initiatives designed to accelerate research focused on progressive MS.
1) Challenge Awards -These are designed to encourage and nurture scientific innovation in the following focus areas:
-- Phenotype/Genotype and pathophysiological mechanisms of progressive MS
-- Development of new and existing pre-clinical models for progressive disease based on community consensus building
-- Discovery and validation of proof of concept biomarkers
-- Innovative designs for proof of concept trials of therapeutic agents or therapeutic strategies
2) Infrastructure Awards -These are designed to promote and enhance data sharing and knowledge management and encourage collaboration among researchers by developing enabling technologies and infrastructure for data sharing to support one or more of the Alliance priority research areas.
Support for each of these awards is limited to a maximum of €75,000 in total costs for 12 months. This request for applications (RFA) is open to all international researchers in academic and other non-profit organizations, as well as to researchers in commercial organizations.
The application deadline is January 31, 2014. Details on how to apply for funding can be found at http://www.endprogressivems.org.
To learn more about the Progressive MS Alliance please visit our web site, www.endprogressivems.org.
We are looking forward to innovative proposals from around the world and from all disciplines. If you have an innovative idea or concept, please apply.
Call for Nominations: Barancik Prize for Innovation in Multiple Sclerosis Research
The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality. This annual prize, made possible by the generosity of the Charles and Margery Barancik SO Foundation, is $100,000 to be used at the discretion of the recipient.
Criteria and Nominations
The goal of the prize is to recognize innovation in scientific research in the field of multiple sclerosis. Nominations must be submitted on behalf an individual, or team of individuals, by one or more colleagues or mentors. Self-nominations are not permitted. Nomination letters should include current institution and contact information of the nominee, and should address the nominee’s scientific accomplishments with an emphasis on citing the innovative and impactful aspects of the nominee’s work. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:
• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research
Nominees that exhibit these qualities will be invited to submit a final application that will include an interview by the selection committee.
Any investigator(s) active in MS research is eligible for the prize, and the nominee(s) may be from any institution or organization— public or private, government, as well as commercial entities. Nominees may also be at any stage of their professional career in MS research. There are no specific requirements for residency or citizenship. Nominees need not be current or past grantees of the National MS Society.
Nomination letters should be sent to firstname.lastname@example.org starting November 1, 2013 until the January 31, 2014 deadline to be considered for the 2014 prize. Notification of the recipient shall occur by June 2014 followed by a public announcement.